Novel peptide therapeutics for treatment of infections

Journal of Medical Microbiology

Volumn 58, Issue 8, 2009, Pages 977-987

  Oyston, P C F ^a   Fox, M A ^a   Richards, S J ^a   Clark, G C ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMICROBIAL PEPTIDE EFK17; ANTIVIRUS AGENT; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CYCLOPEPTIDE; CYCLOSPORIN A [3 N METHYL DEXTRO ALANINE 4 N ETHYLVALINE]; CYTOKINE; DAUNORUBICIN; DAUNOXOMES; DEFENSIN; DOXORUBICIN; ISEGANAN; LYSOZYME; MAGAININ 1; MAGAININ 2; MELITTIN; MURAMYL DIPEPTIDE; MURAMYL TRIPEPTIDE; OMIGANAN; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PEPTIDE DERIVATIVE; PEPTIDOGLYCAN RECOGNITION PROTEIN; PEPTIDOGLYCAN RECOGNITION PROTEIN 1; PEPTIDOGLYCAN RECOGNITION PROTEIN 2; PEPTIDOGLYCAN RECOGNITION PROTEIN 3; PEPTIDOGLYCAN RECOGNITION PROTEIN 4; PEXIGANAN ACETATE; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEGRIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIMICROBIAL ACTIVITY; BACTERIOLYSIS; BIOLOGY; CATHETER INFECTION; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG IDENTIFICATION; DRUG MECHANISM; DRUG STABILITY; FOOT ULCER; GRAM POSITIVE INFECTION; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INFECTION; INNATE IMMUNITY; LICENSING; MEDICAL RESEARCH; MUCOSA INFLAMMATION; NONHUMAN; ORAL MUCOSAL DISEASE; PERITONITIS; PRIORITY JOURNAL; REVIEW;

ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; CARRIER PROTEINS; HUMANS; PROTEIN CONFORMATION;

EID: 67650751104     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.011122-0     Document Type: Review

References (112)

1. Allaker, R. P. (2008). Host defence peptides - a bridge between the innate and adaptive immune responses. Trans R Soc Trop Med Hyg 102, 3-4. (Pubitemid 350177424)
2. Billstein, S. A. (1994). How the pharmaceutical industry brings an antibiotic drug to market in the United States. Antimicrob Agents Chemother 38, 2679-2682. (Pubitemid 24374420)
3. Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G. & Hancock, R. E. W. (2005). Impact of LL-37 on anti-infective immunity. J Leukoc Biol 77, 451-459.
4. Brogden, K. A. (2005). Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3, 238-250.
5. Cheng, L., Naumann, T. A., Horswill, A. R., Hong, S. J., Venters, B. J., Tomsho, J. W., Benkovic, S. J. & Keiler, K. C. (2007). Discovery of antibacterial cyclic peptides that inhibit the ClpXP protease. Protein Sci 16, 1535-1542. (Pubitemid 47195681)
6. Cho, J. H., Fraser, I. P., Fukase, K., Kusumoto, S., Fujimoto, Y., Stahl, G. L. & Ezekowitz, R. A. B. (2005). Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity. Blood 106, 2551-2558. (Pubitemid 41510833)
7. Colas, P., Cohen, B., Jessen, T., Grishina, I., Mccoy, J. & Brent, R. (1996). Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature 380, 548-550. (Pubitemid 26110646)
8. Dartois, V., Sanchez-Quesada, J., Cabezas, E., Chi, E., Dubbelde, C., Dunn, C., Granja, J., Gritzen, C., Weinberger, D. & other authors (2005). Systemic antibacterial activity of novel synthetic cyclic peptides. Antimicrob Agents Chemother 49, 3302-3310. (Pubitemid 41060575)
9. De Clercq, E. (2005). Emerging anti-HIV drugs. Expert Opin Emerg Drugs 10, 241-273.
10. Depauw, P., Neyt, C., Vanderwinkel, E., Wattiez, R. & Falmagne, P. (1995). Characterization of human serum N-acetylmuramyl-L-alanine amidase purified by affinity chromatography. Protein Expr Purif 6, 371-378.
11. Domagk, G. (1935). A new class of disinfectant. Dtsch Med Wochenschr 61, 829-832.
12. Dziarski, R., Platt, K. A., Gelius, E., Steiner, H. & Gupta, D. (2003). Defect in neutrophil killing and increased susceptibility to infection with nonpathogenic gram-positive bacteria in peptidoglycan recognition protein-S (PGRP-S)-deficient mice. Blood 102, 689-697. (Pubitemid 36841993)
13. Eldridge W., Fitzgerald K., Cooley N. & McGregor D. (2006). Peptide stabilizer compounds and screening methods. Patent Application WO2006097748.
14. Elvin, S. J., Eyles, J. E., Howard, K. A., Ravichandran, E., Somavarappu, S., Alpar, H. O. & Williamson, E. D. (2006). Protection against bubonic and pneumonic plague with a single dose microencapsulated sub-unit vaccine. Vaccine 24, 4433-4439.
15. Falciani, C., Lozzi, L., Pini, A. & Bracci, L. (2005). Bioactive peptides from libraries. Chem Biol 12, 417-426.
16. Fernandez-Lopez, S., Kim, H. S., Choi, E. C., Delgado, M., Granja, J. R., Khasanov, A., Kraehenbuehl, K., Long, G., Weinberger, D. A. & other authors (2001). Antibacterial agents based on the cyclic D,Lalpha-peptide architecture. Nature 412, 452-455. (Pubitemid 32702711)
17. Flick-Smith, H. C., Eyles, J. E., Hebdon, R., Waters, E. L., Beedham, R. J., Stagg, T. J., Miller, J., Alpar, H. O., Baillie, L. W. J. & Williamson, E. D. (2002). Mucosal or parenteral administration of microsphereassociated Bacillus anthracis protective antigen protects against anthrax infection in mice. Infect Immun 70, 2022-2028. (Pubitemid 34242204)
18. Flisiak, R., Horban, A., Kierkus, J., Stanczak, J., Cielnak, I., Stanczak, G. P., Wiercinska-Drapalo, A., Siwak, E., Higersberger, J. & other authors (2006). The cyclophilin inhibitor DEBIO-025 has a potent dual anti-HIV and anti-HCV activity in treatment-naive HIV/HCV co-infected subjects. Hepatology 44, 1130.
19. Flisiak, R., Horban, A., Gallay, P., Bobardt, M., Selvarajah, S., Wiercinska-Drapalo, A., Siwak, E., Cielniak, I., Higersberger, J. & other authors (2008). The cyclophilin inhibitor debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus. Hepatology 47, 817-826.
20. Fogueri, L. R. & Singh, S. (2009). Smart polymers for controlled delivery of proteins and peptides: a review of patents. Recent Pat Drug Deliv Formul 3, 40-48.
21. Ganz, T. & Lehrer, R. I. (1994). Defensins. Curr Opin Immunol 6, 584-589.
22. Gelius, E., Persson, C., Karlsson, J. & Steiner, H. (2003). A mammalian peptidoglycan recognition protein with N-acetylmuramoyl-L-alanine amidase activity. Biochem Biophys Res Commun 306, 988-994. (Pubitemid 36776228)
23. Giuliani, A., Pirri, G. & Nicoletto, S. F. (2007). Antimicrobial peptides: an overview of a promising class of therapeutics. Cent Eur J Biol 2, 1-33. (Pubitemid 46450753)
24. Goldberg, A. L., Akopian, T. N., Kisselev, A. F., Lee, D. H. & Rohrwild,M. (1997). New insights into the mechanisms and importance of the proteasome in intracellular protein degradation. Biol Chem 378, 131-140. (Pubitemid 27230595)
25. Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M. & Wilson, J. M. (1997). Human beta-defensin-1 is a saltsensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88, 553-560. (Pubitemid 27154420)
26. Grace, M. J., Lee, S., Bradshaw, S., Chapman, J., Spond, J., Cox, S., DeLorenzo, M., Brassard, D., Wylie, D. & other authors (2005). Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway. J Biol Chem 280, 6327-6336.
27. Guan, R., Malchiodi, E. L., Wang, Q., Schuck, P. & Mariuzza, R. A. (2004a). Crystal structure of the C-terminal peptidoglycan-binding domain of human peptidoglycan recognition protein I alpha. J Biol Chem 279, 31873-31882. (Pubitemid 39037860)
28. Guan, R., Roychowdhury, A., Ember, B., Kumar, S., Boons, G.-J. & Mariuzza, R. A. (2004b). Structural basis for peptidoglycan binding by peptidoglycan recognition proteins. Proc Natl Acad Sci U S A 101, 17168-17173. (Pubitemid 39627792)
29. Guan, R., Wang, Q., Sundberg, E. J. & Mariuzza, R. A. (2005). Crystal structure of human peptidoglycan recognition protein S (PGRP-S) at 1.70 angstrom resolution. J Mol Biol 347, 683-691. (Pubitemid 40357912)
30. Guan, R., Brown, P. H., Swaminathan, C. P., Roychowdhury, A., Boons, G.-J. & Mariuzza, R. A. (2006). Crystal structure of human peptidoglycan recognition protein I alpha bound to a muramyl pentapeptide from Gram-positive bacteria. Protein Sci 15, 1199-1206.
31. Gururaja, T. L., Narasimhamurthy, S., Payan, D. G. & Anderson, D. C. (2000). A novel artificial loop scaffold for the noncovalent constraint of peptides. Chem Biol 7, 515-527. (Pubitemid 30466986)
32. Hancock, R. E. W. (1984). Alterations in outer-membrane permeability. Annu Rev Microbiol 38, 237-264.
33. Hancock, R. E. W. (2001). Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect Dis 1, 156-164. (Pubitemid 33586049)
34. Harris, A. G. (1994). Somatostatin and somatostatin analogs - pharmacokinetics and pharmacodynamic effects. Gut 35, S1-S4. (Pubitemid 24157987)
35. Harris, J. M. & Chess, R. B. (2003). Effect of pegylation on pharmaceuticals. Nat Rev Drug Discov 2, 214-221.
36. Hatziioannou, T., Perez-Caballero, D., Cowan, S. & Bieniasz, P. D. (2005). Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. J Virol 79, 176-183. (Pubitemid 39648375)
37. He, X. H., Shaw, P. C. & Tam, S. C. (1999). Reducing the immunogenicity and improving the in vivo activity of trichosanthin by site-directed PEGylation. Life Sci 65, 355-368. (Pubitemid 29325279)
38. Heithoff, D. M., Sinsheimer, R. L., Low, D. A. & Mahan, M. J. (1999). An essential role for DNA adenine methylation in bacterial virulence. Science 284, 967-970. (Pubitemid 29288436)
39. Herrmann, E., Flisiak, R., Horban, A., Crabbe, R., Porchet, H., Nicolas, V., Scalfaro, P. & Zeuzem, S. (2007). Viral kinetics during 14-day treatment with debio-025 demonstrate efficient blocking of viral replication in different HCV genotypes without signs of emerging viral resistance. J Hepatol 46, 88.
40. Hilt, W. & Wolf, D. H. (1996). Proteasomes: destruction as a programme. Trends Biochem Sci 21, 96-102.
41. Hong, S. Y., Oh, J. E. & Lee, K. H. (1999). Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. Biochem Pharmacol 58, 1775-1780. (Pubitemid 29505418)
42. Horswill, A. R., Savinov, S. N. & Benkovic, S. J. (2004). A systematic method for identifying small-molecule modulators of protein-protein interactions. Proc Natl Acad Sci U S A 101, 15591-15596. (Pubitemid 39473532)
43. Hühne, R., Koch, F.-T. & Sühnel, J. (2007). A comparative view at comprehensive information resources on three-dimensional structures of biological macro-molecules. Brief Funct Genomics Proteomics 6, 220-239. (Pubitemid 351863878)
44. Irache, J. M., Salman, H. H., Gamazo, C. & Espuelas, S. (2008). Mannose-targeted systems for the delivery of therapeutics. Expert Opin Drug Deliv 5, 703-724.
45. Irwin, J. J. (2006). How good is your screening library? Curr Opin Chem Biol 10, 352-356.
46. Jacob, M. K., Leena, S. & Kumar, K. S. (2008). Peptide-polymer biotherapeutic synthesis on novel cross-linked beads with "Spatially Tunable" and "Isolated" functional sites. Biopolymers 90, 512-525.
47. Jenssen, H., Hamill, P. & Hancock, R. E. W. (2006). Peptide antimicrobial agents. Clin Microbiol Rev 19, 491-511.
48. John, H., Maronde, E., Forssmann, W. G., Meyer, M. & Adermann, K. (2008). N-terminal acetylation protects glucagon-like peptide GLP-1-(7-34)-amide from DPP-IV-mediated degradation retaining cAMPand insulin-releasing capacity. Eur J Med Res 13, 73-78.
49. Julio, S. M., Heithoff, D. M., Provenzano, D., Klose, K. E., Sinsheimer, R. L., Low, D. A. & Mahan, M. J. (2001). DNA adenine methylase is essential for viability and plays a role in the pathogenesis of Yersinia pseudotuberculosis and Vibrio cholerae. Infect Immun 69, 7610-7615. (Pubitemid 33086589)
50. Kang, D., Liu, G., Lundstrom, A., Gelius, E. & Steiner, H. (1998). A peptidoglycan recognition protein in innate immunity conserved from insects to humans. Proc Natl Acad Sci U S A 95, 10078-10082. (Pubitemid 28415297)
51. Keiler, K. C., Waller, P. R. H. & Sauer, R. T. (1996). Role of a peptide tagging system in degradation of proteins synthesized from damaged messenger RNA. Science 271, 990-993. (Pubitemid 26066397)
52. Kemp, S. F., Fielder, P. J., Attie, K. M., Blethen, S. L., Reiter, E. O., Ford, K. M., Marian, M., Dao, L. N., Lee, H. J. & Saenger, P. (2004). Pharmacokinetic and pharmacodynamic characteristics of a longacting growth hormone (GH) preparation (nutropin depot) in GHdeficient children. J Clin Endocrinol Metab 89, 3234-3240. (Pubitemid 38951887)
53. Khaksa, G., D'Souza, R., Lewis, S. & Udupa, N. (2000). Pharmacokinetic study of niosome encapsulated insulin. Indian J Exp Biol 38, 901-905. (Pubitemid 30784853)
54. Kumar, S., Roychowdhury, A., Ember, B., Wang, Q., Guan, R. J., Mariuzza, R. A. & Boons, G. J. (2005). Selective recognition of synthetic lysine and meso-diaminopimelic acid-type peptidoglycan fragments by human peptidoglycan recognition proteins I alpha and S. J Biol Chem 280, 37005-37012. (Pubitemid 41587784)
55. Levchenko, I., Seidel, M., Sauer, R. T. & Baker, T. A. (2000). A specificity-enhancing factor for the ClpXP degradation machine. Science 289, 2354-2356. (Pubitemid 30739740)
56. Li, M., Yu, D. H. & Cai, H. (2008). The synthetic antimicrobial peptide KLKL5KLK enhances the protection and efficacy of the combined DNA vaccine against Mycobacterium tuberculosis. DNA Cell Biol 27, 405-413.
57. Liu, C., Xu, Z. J., Gupta, D. & Dziarski, R. (2001). Peptidoglycan recognition proteins - a novel family of four human innate immunity pattern recognition molecules. J Biol Chem 276, 34686-34694. (Pubitemid 37384465)
58. Llobet, E., Tomas, J. M. & Bengoechea, J. A. (2008). Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology 154, 3877-3886.
59. Lu, X., Wang, M. H., Qi, J., Wang, H. T., Li, X. N., Gupta, D. & Dziarski, R. (2006). Peptidoglycan recognition proteins are a new class of human bactericidal proteins. J Biol Chem 281, 5895-5907. (Pubitemid 43847690)
60. Luban, J., Bossolt, K. L., Franke, E. K., Kalpana, G. V. & Goff, S. P. (1993). Human-immunodeficiency-virus type-1 Gag protein binds to cyclophilin-A and cyclophilin-B. Cell 73, 1067-1078. (Pubitemid 23180482)
61. Marr, A. K., Gooderham, W. J. & Hancock, R. E. W. (2006). Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6, 468-472. (Pubitemid 44340665)
62. Matsumoto, S., Akashi, H. & Taira, K. (2006). Screening and determination of gene function using randomized ribozyme and siRNA libraries. Handb Exp Pharmacol 173, 197-221.
63. Mellroth, P., Karlsson, J. & Steiner, H. (2003). A scavenger function for a Drosophila peptidoglycan recognition protein. J Biol Chem 278, 7059-7064. (Pubitemid 36800702)
64. Moore, S. D. & Sauer, R. T. (2005). Ribosome rescue: tmRNA tagging activity and capacity in Escherichia coli. Mol Microbiol 58, 456-466. (Pubitemid 41476161)
65. Naumann, T. A., Tavassoli, A. & Benkovic, S. J. (2008). Genetic selection of cyclic peptide dam methyltransferase inhibitors. ChemBioChem 9, 194-197. (Pubitemid 351196784)
66. Neuwald, A. F., Aravind, L., Spouge, J. L. & Koonin, E. V. (1999). AAA(+): a class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res 9, 27-43. (Pubitemid 29095146)
67. Noyer-Weidner, M. & Trautner, T. A. (1993). Methylation of DNA in prokaryotes. EXS 64, 39-108.
68. Odegrip, R., Coomber, D., Eldridge, B., Hederer, R., Kuhlman, P. A., Ullman, C., FitzGerald, K. & McGregor, D. (2004). CIS display: in vitro selection of peptides from libraries of protein-DNA complexes. Proc Natl Acad Sci U S A 101, 2806-2810. (Pubitemid 38327692)
69. Oren, Z. & Shai, Y. (2000). Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. Biochemistry 39, 6103-6114. (Pubitemid 30327085)
70. Pakkala, M., Hekim, C., Soininen, P., Leinonen, J., Koistinen, H., Weisell, J., Stenman, U. H., Vepsalainen, J. & Narvanen, A. (2007). Activity and stability of human kalikrein-2-specific linear and cyclic peptide inhibitors. J Pept Sci 13, 348-353. (Pubitemid 46730574)
71. Papageorgiou, C., Borer, X. & French, R. R. (1994). Calcineurin has a very tight-binding pocket for the side-chain of residue-4 of cyclosporine. Bioorg Med Chem Lett 4, 267-272. (Pubitemid 24127119)
72. Ptak, R. G., Gallay, P. A., Jochmans, D., Halestrap, A. P., Ruegg, U. T., Pallansch, L. A., Bobardt, M. D., de Bethune, M. P., Neyts, J. & other authors (2008). Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent. Antimicrob Agents Chemother 52, 1302-1317.
73. Qiu, D., Eisinger, V. M., Head, N. E., Pier, G. B. & Yu, H. D. (2008). ClpXP proteases positively regulate alginate overexpression and mucoid conversion in Pseudomonas aeruginosa. Microbiology 154, 2119-2130.
74. Ramon, J., Saez, V., Baez, R., Aldana, R. & Hardy, E. (2005). PEGylated interferon-alpha 2b: a branched 40K polyethylene glycol derivative. Pharm Res 22, 1374-1386. (Pubitemid 41176042)
75. Reichert, J. & Sühnel, J. (2002). The IMB Jena Image Library of Biological Macromolecules: 2002 update. Nucleic Acids Res 30, 253-254. (Pubitemid 34679557)
76. Robinson, V. L., Oyston, P. C. F. & Titball, R. W. (2005). A dam mutant of Yersinia pestis is attenuated and induces protection against plague. FEMS Microbiol Lett 252, 251-256. (Pubitemid 41531651)
77. Royet, J. & Dziarski, R. (2007). Peptidoglycan recognition proteins: pleiotropic sensors and effectors of antimicrobial defences. Nat Rev Microbiol 5, 264-277. (Pubitemid 46443603)
78. Samad, A., Sultana, Y. & Aqil, M. (2007). Liposomal drug delivery systems: an update review. Curr Drug Deliv 4, 297-305. (Pubitemid 47554274)
79. Sang, Y., Ramanathan, B., Ross, C. R. & Blecha, F. (2005). Gene silencing and overexpression of porcine peptidoglycan recognition protein long isoforms: involvement in beta-defensin-1 expression. Infect Immun 73, 7133-7141. (Pubitemid 41587610)
80. Scott, C. P., Abel-Santos, E., Wall, M., Wahnon, D. C. & Benkovic, S. J. (1999). Production of cyclic peptides and proteins in vivo. Proc Natl Acad Sci U S A 96, 13638-13643.
81. Scott, M. G., Dullaghan, E., Mookherjee, N., Glavas, N., Waldbrook, M., Thompson, A., Wang, A. K., Lee, K., Doria, S. & other authors (2007). An anti-infective peptide that selectively modulates the innate immune response. Nat Biotechnol 25, 465-472. (Pubitemid 46572850)
82. Simoes, S., Moreira, J. N., Fonseca, C., Duzgunes, N. & de Lima, M. C. P. (2004). On the formulation of pH-sensitive long circulation times. Adv Drug Deliv Rev 56, 947-965. (Pubitemid 38520203)
83. Sokolskaja, E., Sayah, D. M. & Luban, J. (2004). Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. J Virol 78, 12800-12808. (Pubitemid 39507788)
84. Steinberg, D. A., Hurst, M. A., Fujii, C. A., Kung, A. H. C., Ho, J. F., Cheng, F. C., Loury, D. J. & Fiddes, J. C. (1997). Protegrin-1: a broadspectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother 41, 1738-1742. (Pubitemid 27339878)
85. Steiner, H., Hultmark, D., Engstrom, A., Bennich, H. & Boman, H. G. (1981). Sequence and specificity of two anti-bacterial proteins involved in insect immunity. Nature 292, 246-248. (Pubitemid 11001840)
86. Steinkasserer, A., Harrison, R., Billich, A., Hammerschmid, F., Werner, G., Wolff, B., Peichl, P., Palfi, G., Schnitzel, W. & other authors (1995). Mode of action of Sdz Nim-811, a nonimmunosuppressive cyclosporine-A analog with activity against human-immunodeficiency-virus type-1 (HIV-1): interference with early and late events in HIV-1 replication. J Virol 69, 814-824.
87. Stromstedt, A. A., Pasupuleti, M., Schmidtchen, A. & Malmsten, M. (2009). Evaluation of strategies for improving proteolytic resistance of antimicrobial peptides by using variants of EFK17, an internal segment of LL-37. Antimicrob Agents Chemother 53, 593-602.
88. Sun, C., Mathur, P., Dupuis, J., Tizard, R., Ticho, B., Crowell, T., Gardner, H., Bowcock, A. M. & Carulli, J. (2006). Peptidoglycan recognition proteins PGLRP3 and PGLRP4 are encoded from the epidermal differentiation complex and are candidate genes for the Psors4 locus on chromosome 1q21. Hum Genet 119, 113-125. (Pubitemid 43300203)
89. Swaminathan, C. P., Brown, P. H., Roychowdhury, A., Wang, Q., Guan, R. J., Silverman, N., Goldman, W. E., Boons, G. J. & Mariuzza, R. A. (2006). Dual strategies for peptidoglycan discrimination by peptidoglycan recognition proteins (PGRPs). Proc Natl Acad Sci U S A 103, 684-689. (Pubitemid 43153086)
90. Tan, D. S. (2005). Diversity-oriented synthesis: exploring the intersections between chemistry and biology. Nat Chem Biol 1, 74-84.
91. Tavassoli, A. & Benkovic, S. J. (2007). Split-intein mediated circular ligation used in the synthesis of cyclic peptide libraries in E. coli. Nat Protoc 2, 1126-1133. (Pubitemid 46908238)
92. Taylor, V. L., Titball, R. W. & Oyston, P. C. F. (2005). Oral immunization with a Dam mutant of Yersinia pseudotuberculosis protects against plague. Microbiology 151, 1919-1926. (Pubitemid 40909034)
93. Thongyoo, P., Roque-Rosell, N., Leatherbarrow, R. J. & Tate, E. W. (2008). Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides. Org Biomol Chem 6, 1462-1470.
94. Ulrich, H., Trujillo, C. A., Nery, A. A., Alves, J. M., Majumder, P., Resende, R. R. & Martins, A. H. (2006). DNA and RNA aptamers: from tools for basic research towards therapeutic applications. Comb Chem High Throughput Screen 9, 619-632. (Pubitemid 44320411)
95. Uttamchandani, M., Wang, J. & Yao, S. Q. (2006). Protein and small molecule microarrays: powerful tools for high-throughput proteomics. Mol Biosyst 2, 58-68.
96. Vaara, M. (1992). Agents that increase the permeability of the outer membrane. Microbiol Rev 56, 395-411.
97. Vives, E., Schmidt, J. & Pelegrin, A. (2008). Cell-penetrating and celltargeting peptides in drug delivery. Biochim Biophys Acta 1786, 126-138.
98. Wang, Z. M., Li, X. N., Cocklin, R. R., Wang, M. H., Wang, M., Fukase, K., Inamura, S., Kusumoto, S., Gupta, D. & Dziarski, R. (2003). Human peptidoglycan recognition protein-L is an N-acetylmuramoyl-L-alanine amidase. J Biol Chem 278, 49044-49052.
99. Wang, M., Liu, L.-H., Wang, S., Li, X., Lu, X., Gupta, D. & Dziarski, R. (2007). Human peptidoglycan recognition proteins require zinc to kill both Gram-positive and Gram-negative bacteria and are synergistic with antibacterial peptides. J Immunol 178, 3116-3125. (Pubitemid 46333193)
100. Wang, G., Li, X. & Wang, Z. (2009). APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 37, D933-D937.
101. Webb, T. R. (2005). Current directions in the evolution of compound libraries. Curr Opin Drug Discov Devel 8, 303-308. (Pubitemid 40593424)
102. Wenger, R. (1986). Cyclosporine and analogs - structural requirements for immunosuppressive activity. Transplant Proc 18, 213-218. (Pubitemid 17223797)
103. Werner, T., Liu, G., Kang, D., Ekengren, S., Steiner, H. & Hultmark, D. (2000). A family of peptidoglycan recognition proteins in the fruit fly Drosophila melanogaster. Proc Natl Acad Sci U S A 97, 13772-13777.
104. Wirsching, F., Keller, M., Hildmann, C., Riester, D. & Schwienhorst, A. (2003). Directed evolution towards protease-resistant hirudin variants. Mol Genet Metab 80, 451-462. (Pubitemid 37491207)
105. Woodburn, K. W., Wilson, S. D., Fong, K. L., Schatz, P. J., Spainhour, C. B. & Norton, D. (2009). Chronic pharmacological and safety evaluation of HematideTM, a PEGylated peptidic erythropoiesisstimulating agent, in rodents. Basic Clin Pharmacol Toxicol 104, 155-163.
106. Wrighton, N. C., Farrell, F. X., Chang, R., Kashyap, A. K., Barbone, F. P., Mulcahy, L. S., Johnson, D. L., Barrett, R. W., Jolliffe, L. K. & Dower, W. J. (1996). Small peptides as potent mimetics of the protein hormone erythropoietin. Science 273, 458-463. (Pubitemid 26286441)
107. Yoshida, H., Kinoshita, K. & Ashida, M. (1996). Purification of a peptidoglycan recognition protein from hemolymph of the silkworm, Bombyx mori. J Biol Chem 271, 13854-13860. (Pubitemid 26185431)
108. Yoshioka, M., Fukuishi, N., Ku, Y., Yamanobe, H., Ohsaki, K., Kawasoe, Y., Murata, M., Ishzumi, A., Nishi, Y. & other authors (2008). Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity. Biol Pharm Bull 31, 212-216. (Pubitemid 351198391)
109. Zaiou, M. (2007). Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J Mol Med 85, 317-329. (Pubitemid 46452258)
110. Zasloff, M. (1987). Magainins, a class of antimicrobial peptides from Xenopus skin - isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A 84, 5449-5453. (Pubitemid 17129018)
111. Zenke, G., Baumann, G., Wenger, R., Hiestand, P., Quesniaux, V., Andersen, E. & Schreier, M. H. (1993). Molecular mechanisms of immunosuppression by cyclosporins. Ann N Y Acad Sci 685, 330-335.
112. Zhang, Y., van der Fits, L., Voerman, J. S., Melief, M.-J., Laman, J. D., Wang, M., Wang, H., Wang, M., Li, X. & other authors (2005). Identification of serum N-acetylmuramoyl-L-alanine amidase as liver peptidoglycan recognition protein 2. Biochim Biophys Acta 1752, 34-46. (Pubitemid 41207248)